Maurizio Nicolelli
Analyst · Cowen
Thank you, Rohit, and thanks, everyone, for joining us this morning. I will provide insights into our financial performance for the second quarter of 2021, followed by our updated outlook for 2021. As Rohit mentioned, this was our best result in the last 23 quarters, with revenue of $275.1 million, up 23.6% year-over-year, while adjusted earnings per share was $1.14. All revenue growth numbers mentioned hereafter are on a constant currency basis. Revenue from our Operations Management business as defined by 3 reportable segments, excluding Analytics, was $163.7 million, up 14.9% year-over-year. Sequentially from the first quarter, revenue was up 2.8%. Our Insurance segment generated revenue of $94.7 million, up 14.9% year-over-year, driven by an expansion in existing client relationships and higher volumes. Compared to the first quarter of 2021, revenue was up 3.8%. The Insurance vertical, consisting of insurance operations management and analytics businesses, grew 3.8% sequentially from the first quarter. Healthcare reported revenue of $28.2 million, up 13.1% year-over-year, driven by higher volumes in our Clinical Services business and new wins of 2020. The Healthcare vertical consisting of our health care operations management and analytics businesses grew 3.7% sequentially from the first quarter. Emerging reported revenue of $40.7 million, up 16.2% year-over-year. This growth was driven by new client wins of 2020 and 2021 in Finance & Accounting, banking and utilities. Sequentially, Emerging revenue grew 8.1%. The Emerging vertical, consisting of the emerging operations management and analytics businesses grew 8.2% sequentially from the first quarter. Analytics revenue totaled $111.4 million, up 35.1% year-over-year. Analytics was 40.5% of revenue in the second quarter and had its highest growth rate in the last 8 quarters. This growth was driven by higher volumes across all industry verticals with expansion in client relationships, particularly banking and the ramping up of new wins in 2020 and 2021 as clients embrace our data-led solutions. Compared to the first quarter of 2021, revenue was up 8.8%. Our SG&A expenses were 20.4% of revenue, up 160 basis points year-over-year, driven by investments in front-end sales and onetime COVID-related spending totaling $2.2 million for the health and safety initiatives we undertook for our employees. Our adjusted operating margin for the quarter was 17.9%, up 850 basis points year-over-year, driven by operating leverage from higher revenue, continued cost optimization measures, lower infrastructure expenses and reduced discretionary spending. Our adjusted operating margin was down 230 basis points from the first quarter, driven by annual salary increments and onetime COVID-related expenses as mentioned earlier. Our adjusted EPS for the quarter was $1.14, up 115% year-over-year on a reported basis. EXL's balance sheet continues to remain strong, with a focus on liquidity and cash flow generation from operations. Our cash and short-term investments at June 30 was $295 million, and our debt was $165 million, for a net cash position of $130 million. During the second quarter, we reduced our revolver by $74 million. Our DSO at June 30 was 58 days. Now moving to our 6-month performance. Our revenue for the period was $536.5 million, up 13.5% year-over-year. This growth was broad-based, driven by Analytics, Insurance and Healthcare. Adjusted operating margin for the period was 19%, up 670 basis points year-over-year. Adjusted EPS for the period was $2.32, up 72% year-over-year on a reported basis. In the first 6 months of the year, we generated cash flow from operations of $53.9 million compared to $58.9 million in the same period last year. Now moving on to our outlook for the year. The economic environment in the U.S. and U.K. is improving, and we have a strong pipeline which continues to expand. In our non-U.S. delivery centers, we will continue to assess the impact of the pandemic and respond to changing circumstances with the primary focus being the health and safety of our staff. We have proven that we can manage our delivery commitments, and we will continue to be responsive to changing conditions. Based on our strong first half results, the continued strong demand for our services and solutions, particularly analytics, and improved visibility for the second half of 2021, we are increasing our revenue guidance for 2021 to be in the range of $1.08 billion to $1.1 billion, up $35 million at the midpoint and $30 million at the top end of the range. This represents a year-over-year growth rate of 13% to 15% on a reported basis and 12% to 14% on a constant currency basis. In 2021, we expect Analytics to grow in the low 20% range and Operations Management to grow in the 6% to 8% range. We expect a foreign exchange gain between $3 million to $4 million, net interest expense of $2 million to $3 million and our effective tax rate to be in the range of 23.5% to 24.5%. In terms of capital allocation, we will continue to invest in analytics, digital solutions and technology. We expect capital expenditures to be in the range of $35 million to $40 million. During the first half of the year, we repurchased 600,000 shares at a cost of $55.4 million. We anticipate buying back our shares in the second half of 2021 at a pace similar to the first half of the year. Based on the above, we expect our adjusted EPS to be in the range of $4.30 to $4.50, up 22% to 27%, driven by increased revenue in 2021. In conclusion, we had a good start to 2021 despite the challenges created by the recent pandemic surges. We have demonstrated a flexible and resilient business model. Our investments in analytics, data and digital solutions are successfully meeting our clients' transformation agendas, which is accelerating our pipeline of opportunities. Now Rohit and I will be happy to take your questions.